IMCD (OTC:IMCDY) Upgraded to “Equal Weight” at Barclays

Barclays upgraded shares of IMCD (OTC:IMCDYGet Rating) from an underweight rating to an equal weight rating in a report released on Monday morning, The Fly reports.

IMCD Price Performance

Shares of IMCDY opened at $75.78 on Monday. The firm has a 50-day moving average of $77.76 and a 200-day moving average of $77.03. IMCD has a one year low of $53.55 and a one year high of $87.35.

IMCD Company Profile

(Get Rating)

IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company offers enzymes, surfactants, biocides, chelates, rheology modifiers, solubilisers, silicones, solvents, and functional additives; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, UV sunscreens, rheology modifiers, thickeners, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents.

Featured Stories

The Fly logo

Receive News & Ratings for IMCD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMCD and related companies with's FREE daily email newsletter.